Privi Speciality Chemicals Ltd

Privi Speciality Chemicals Ltd has a market capitalization of INR 14,873.7 million and a price-to-earnings ratio of 47.4, which is above the industry median of 32.5. The company's liquidity position is not assessable due to missing balance-sheet inputs and no going-concern language in source documents. The company's net income of INR 313.7 million in the latest period reflects a net margin of 6.76%, which is below the industry median of 8.2%. The company's operating income of INR 622.4 million corresponds to an operating margin of 13.4%, which is also below the industry median of 16.8%. The gross profit of INR 1.68 billion represents a gross margin of 36.3%, which is slightly below the industry median of 37.1%. These metrics suggest that the company is underperforming relative to its peers in terms of profitability and returns. The company's revenue of INR 4.64 billion is concentrated in a few key markets, with India accounting for 85% of total revenue. The company has no significant international operations, which increases its exposure to domestic economic conditions. The company's growth trajectory is uncertain, with no clear guidance provided in the latest financial reports. The company's revenue has remained relatively stable over the past few years, with no significant growth or decline observed. The company's risk assessment indicates a low dilution potential, with no significant dilution events reported in the latest financial statements. The company's liquidity risk is unknown due to missing balance-sheet inputs and no going-concern language in source documents. The company's recent events include a strong buy recommendation from one analyst and a buy recommendation from another, with a mean price target of INR 3,789.50.